Robert Spurr - 15 Feb 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
U.S. President-Pharma Business
Signature
/s/ Debra E. Levin, attorney-in-fact
Issuer symbol
BHC
Transactions as of
15 Feb 2022
Net transactions value
-$81,340
Form type
4
Filing time
17 Feb 2022, 15:36:13 UTC
Previous filing
20 Jan 2022
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Sale $81,340 -3,251 -5.1% $25.02 60,299 15 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.